The Trump Administration’s abrupt cancellation of National Institutes of Health meetings and grant reviews has sparked concerns that medical breakthroughs will be stalled and DEI initiatives shut down.

A pause in communication is typical during a new administration’s transition. But some scientists fear that tying up NIH grant funding for any length of time could disrupt ongoing, time-sensitive clinical research.

In an unprecedented move, research-grant reviews have been suspended indefinitely at the world’s largest public funder of biomedical research.